Home

Movers roundup: Entravision, Amylin, Novo Nordisk

By Associated Press
June 6, 2008 | Comments (0)

Recs

0

Among the stock activity stories for Friday, June 6, from AP Financial News:

NEW YORK (AP) _ Shares of Spanish-language media company Entravision Communications Corp. sank Friday after a Citi analyst downgraded the stock, citing concerns over lower ad revenue and a legal dispute.

NEW YORK (AP) _ Danish drug developer Novo Nordisk said Friday its late-stage type 2 diabetes drug liraglutide controlled blood sugar better than a rival drug from Amylin Pharmaceuticals Inc., sending Amylin shares down.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

DocumentId: 660343, ~/articles/articlehandler.aspx, 12/1/2008 10:38:40 PM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.